SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Organogenesis Holdings IncNewsfile Corp • 08/30/22
Organogenesis Receives FDA Clearance for Next Generation PuraPly Surgical SolutionGlobeNewsWire • 08/15/22
Organogenesis Holdings Inc. (ORGO) CEO Gary Gillheeney on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/09/22
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2022 Financial Results on August 9, 2022GlobeNewsWire • 06/30/22
Organogenesis Holdings Inc. (ORGO) CEO Gary Gillheeney on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/11/22
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Organogenesis Holdings Inc. for Potential Breaches of Fiduciary Duty By Its Board of DirectorsPRNewsWire • 05/04/22
Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Spring 2022 ConferenceGlobeNewsWire • 04/05/22
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2022 Financial Results on May 10, 2022GlobeNewsWire • 04/05/22
Organogenesis Named One of 50 Highest Growth Companies in Massachusetts by the Boston Business JournalGlobeNewsWire • 03/17/22
Organogenesis Holdings Inc. to Present at the Oppenheimer Healthcare ConferenceGlobeNewsWire • 03/08/22
Organogenesis Holdings Inc. (ORGO) CEO Gary Gillheeney on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/02/22
Organogenesis Holdings Inc. Reports Fourth Quarter and Fiscal Year 2021 Financial Results; Introduces Fiscal Year 2022 GuidanceGlobeNewsWire • 03/01/22
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in FebruaryGlobeNewsWire • 02/11/22
Deadline Today Alert: The Schall Law Firm Encourages Investors in Organogenesis Holdings Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 02/08/22